Spontaneous HBeAg seroconversion and loss of hepatitis B virus DNA after acute flare due to development of drug resistant mutants during entecavir monotherapy

2009 ◽  
Vol 39 (1) ◽  
pp. 14-20 ◽  
Author(s):  
Ri-Cheng Mao ◽  
You-Kuan Yin ◽  
Yan-Li Qin ◽  
Xiang-Hui Wu ◽  
Xin-Hua Weng ◽  
...  
2014 ◽  
Vol 58 (04) ◽  
pp. 348-355
Author(s):  
Q. ZHOU ◽  
E. CHEN ◽  
L. CHEN ◽  
Y. NONG ◽  
X. CHENG ◽  
...  

2007 ◽  
Vol 51 (6) ◽  
pp. 2240-2243 ◽  
Author(s):  
M. N. Brunelle ◽  
J. Lucifora ◽  
J. Neyts ◽  
S. Villet ◽  
A. Holy ◽  
...  

ABSTRACT The susceptibilities of drug-resistant hepatitis B virus (HBV) mutants to lamivudine, adefovir, tenofovir, entecavir, and 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine (PMEO-DAPym), a novel acyclic pyrimidine analogue, were assessed in vitro. Most drug-resistant mutants, including multidrug-resistant strains, remained sensitive to tenofovir and PMEO-DAPym. Therefore, the latter molecule deserves further evaluation for the treatment of HBV infection.


2018 ◽  
Vol 7 (1) ◽  
pp. 1-12 ◽  
Author(s):  
Magdalena Agnieszka Budzinska ◽  
Nicholas Adam Shackel ◽  
Stephan Urban ◽  
Thomas Tu

2015 ◽  
Vol 59 (2) ◽  
pp. 58-60
Author(s):  
Fumio Itoh ◽  
Yoshiyuki Watanabe ◽  
Ritsuko Oikawa ◽  
Hiroshi Yotsuyanagi ◽  
Hiroyuki Yamamoto

1988 ◽  
Vol 62 (3) ◽  
pp. 861-865 ◽  
Author(s):  
F Imazeki ◽  
K Yaginuma ◽  
M Omata ◽  
K Okuda ◽  
M Kobayashi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document